1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Radiopharmaceutical Market, By Source
5.1 Introduction
5.2 Nuclear Reactors
5.3 Cyclotrons
6 Global Radiopharmaceutical Market, By Type
6.1 Introduction
6.2 Therapeutic
6.2.1 Alpha Emitters
6.2.2 Beta Emitters
6.2.3 Brachytherapy Isotopes
6.3 Diagnostic
6.3.1 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
6.3.2 Positron Emission Tomography (PET) Radiopharmaceuticals
7 Global Radiopharmaceutical Market, By Radioisotope
7.1 Introduction
7.2 Yttrium-90
7.3 Thallium-201
7.4 Technetium-99
7.5 Strontium -89
7.6 Samarium-153
7.7 Rubidium-82
7.8 Rhenium-186
7.9 Radium-223
7.10 Palladium – 103
7.11 Leutetium-177
7.12 Iridium – 192
7.13 Iodine-131
7.14 Iodine-125
7.15 Iodine-123
7.16 Indium-111
7.17 Holmium-166
7.18 Gallium-68
7.19 Gallium-67
7.20 Fluorine-18
7.21 Fludeoxyglucose – (18F-FDG)
7.22 Erbium-169
7.23 Cesium-131
7.24 Actinium-225
8 Global Radiopharmaceutical Market, By Application
8.1 Introduction
8.2 Thyroid
8.3 Theranostics
8.4 Oncology
8.5 Neurology
8.6 Neuroendocrinology
8.7 Nephrology
8.8 Lymphoma
8.9 Inflammation
8.10 Gastroenterology
8.11 Cardiology
9 Global Radiopharmaceutical Market, By End User
9.1 Introduction
9.2 Ambulatory Surgical Centers
9.3 Cancer Research Institute
9.4 Diagnostic Imaging Centers
9.5 Hospitals
10 Global Radiopharmaceutical Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Lantheus Medical Imaging, Inc
12.2 GE Healthcare
12.3 Advanced Accelerator Applications
12.4 Mallinckrodt
12.5 Bayer AG
12.6 Siemens Healthineers
12.7 IBA Radiopharma Solutions
12.8 Eckert & Ziegler
12.9 Philips
12.10 Jubilant Life Sciences Limited
12.11 Novartis AG
12.12 BWX Technologies, Inc.
12.13 POLATOM
12.14 JSC Isotope
12.15 NTP Radioisotopes SOC Ltd
12.16 Curium
12.17 Australian Nuclear Science and Technology Organization (ANSTO)
12.18 Cardinal Health Inc.
12.19 Covidien Plc
12.20 Positron Corporation
12.21 Monrol Nuclear Products,Inc
12.22 Nordion,Inc.
List of Tables
Table 1 Global Radiopharmaceutical Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Radiopharmaceutical Market Outlook, By Source (2018-2027) ($MN)
Table 3 Global Radiopharmaceutical Market Outlook, By Nuclear Reactors (2018-2027) ($MN)
Table 4 Global Radiopharmaceutical Market Outlook, By Cyclotrons (2018-2027) ($MN)
Table 5 Global Radiopharmaceutical Market Outlook, By Type (2018-2027) ($MN)
Table 6 Global Radiopharmaceutical Market Outlook, By Therapeutic (2018-2027) ($MN)
Table 7 Global Radiopharmaceutical Market Outlook, By Alpha Emitters (2018-2027) ($MN)
Table 8 Global Radiopharmaceutical Market Outlook, By Beta Emitters (2018-2027) ($MN)
Table 9 Global Radiopharmaceutical Market Outlook, By Brachytherapy Isotopes (2018-2027) ($MN)
Table 10 Global Radiopharmaceutical Market Outlook, By Diagnostic (2018-2027) ($MN)
Table 11 Global Radiopharmaceutical Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2018-2027) ($MN)
Table 12 Global Radiopharmaceutical Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2018-2027) ($MN)
Table 13 Global Radiopharmaceutical Market Outlook, By Radioisotope (2018-2027) ($MN)
Table 14 Global Radiopharmaceutical Market Outlook, By Yttrium-90 (2018-2027) ($MN)
Table 15 Global Radiopharmaceutical Market Outlook, By Thallium-201 (2018-2027) ($MN)
Table 16 Global Radiopharmaceutical Market Outlook, By Technetium-99 (2018-2027) ($MN)
Table 17 Global Radiopharmaceutical Market Outlook, By Strontium -89 (2018-2027) ($MN)
Table 18 Global Radiopharmaceutical Market Outlook, By Samarium-153 (2018-2027) ($MN)
Table 19 Global Radiopharmaceutical Market Outlook, By Rubidium-82 (2018-2027) ($MN)
Table 20 Global Radiopharmaceutical Market Outlook, By Rhenium-186 (2018-2027) ($MN)
Table 21 Global Radiopharmaceutical Market Outlook, By Radium-223 (2018-2027) ($MN)
Table 22 Global Radiopharmaceutical Market Outlook, By Palladium – 103 (2018-2027) ($MN)
Table 23 Global Radiopharmaceutical Market Outlook, By Leutetium-177 (2018-2027) ($MN)
Table 24 Global Radiopharmaceutical Market Outlook, By Iridium – 192 (2018-2027) ($MN)
Table 25 Global Radiopharmaceutical Market Outlook, By Iodine-131 (2018-2027) ($MN)
Table 26 Global Radiopharmaceutical Market Outlook, By Iodine-125 (2018-2027) ($MN)
Table 27 Global Radiopharmaceutical Market Outlook, By Iodine-123 (2018-2027) ($MN)
Table 28 Global Radiopharmaceutical Market Outlook, By Indium-111 (2018-2027) ($MN)
Table 29 Global Radiopharmaceutical Market Outlook, By Holmium-166 (2018-2027) ($MN)
Table 30 Global Radiopharmaceutical Market Outlook, By Gallium-68 (2018-2027) ($MN)
Table 31 Global Radiopharmaceutical Market Outlook, By Gallium-67 (2018-2027) ($MN)
Table 32 Global Radiopharmaceutical Market Outlook, By Fluorine-18 (2018-2027) ($MN)
Table 33 Global Radiopharmaceutical Market Outlook, By Fludeoxyglucose – (18F-FDG) (2018-2027) ($MN)
Table 34 Global Radiopharmaceutical Market Outlook, By Erbium-169 (2018-2027) ($MN)
Table 35 Global Radiopharmaceutical Market Outlook, By Cesium-131 (2018-2027) ($MN)
Table 36 Global Radiopharmaceutical Market Outlook, By Actinium-225 (2018-2027) ($MN)
Table 37 Global Radiopharmaceutical Market Outlook, By Application (2018-2027) ($MN)
Table 38 Global Radiopharmaceutical Market Outlook, By Thyroid (2018-2027) ($MN)
Table 39 Global Radiopharmaceutical Market Outlook, By Theranostics (2018-2027) ($MN)
Table 40 Global Radiopharmaceutical Market Outlook, By Oncology (2018-2027) ($MN)
Table 41 Global Radiopharmaceutical Market Outlook, By Neurology (2018-2027) ($MN)
Table 42 Global Radiopharmaceutical Market Outlook, By Neuroendocrinology (2018-2027) ($MN)
Table 43 Global Radiopharmaceutical Market Outlook, By Nephrology (2018-2027) ($MN)
Table 44 Global Radiopharmaceutical Market Outlook, By Lymphoma (2018-2027) ($MN)
Table 45 Global Radiopharmaceutical Market Outlook, By Inflammation (2018-2027) ($MN)
Table 46 Global Radiopharmaceutical Market Outlook, By Gastroenterology (2018-2027) ($MN)
Table 47 Global Radiopharmaceutical Market Outlook, By Cardiology (2018-2027) ($MN)
Table 48 Global Radiopharmaceutical Market Outlook, By End User (2018-2027) ($MN)
Table 49 Global Radiopharmaceutical Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 50 Global Radiopharmaceutical Market Outlook, By Cancer Research Institute (2018-2027) ($MN)
Table 51 Global Radiopharmaceutical Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
Table 52 Global Radiopharmaceutical Market Outlook, By Hospitals (2018-2027) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
【免責事項】
https://www.marketreport.jp/reports-disclaimer